Nanjing University School of Medicine
2 clinical trials · 2 recruiting · OTHER
Trials by Nanjing University School of Medicine
RECRUITINGPhase 1NCT06285279
The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
This study is a single-center, open-label, dose-escalation exploratory clinical trial, expected to enroll 6 to 12 participants. It will use a BOIN (Bayesian Optimal Interval)...
Sponsor: Nanjing University School of MedicineEnrolling: 241 location
Lupus NephritisANCA-associated VasculitisMembranous Nephropathy - PLA2R Induced+1
RECRUITINGPhase 2NCT07340463
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis...
1. Study Design This is a single-center, prospective, randomized, controlled, exploratory clinical trial. The study is designed to evaluate and compare the efficacy and safety of...
Sponsor: Nanjing University School of MedicineEnrolling: 501 location
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)